Homepage
Open in app
Sign in
Get started
hyasynth
Creating the Cannabinoid Industry
Follow
Following
Organigram Makes Additional $2.5
Organigram Makes Additional $2.5
MONCTON, New Brunswick — () — As an early investor in biosynthesis, Organigram Holdings Inc. (NASDAQ: OGI), (TSX: OGI), the parent company…
hyasynth
Dec 22, 2021
What is biosynthesis and why do we use it?
What is biosynthesis and why do we use it?
With growing interest in the health and wellness sectors, consumers around the world are increasing the demand for natural products. The…
hyasynth
Jun 2, 2021
Hyasynth announces production of >20 rare cannabinoids by fermentation & US patent grant on novel…
Hyasynth announces production of >20 rare cannabinoids by fermentat...
MONTREAL, QUEBEC, CANADA, May 26, 2021 / EINPresswire.com/ — Hyasynth, a sustainable biotechnology company specializing in…
hyasynth
May 26, 2021
Hyasynth completes key commercialization milestone for cannabinoid biosynthesis, receives $2.5
Hyasynth completes key commercialization milestone for cannabinoid ...
Hyasynth receives $2.5 million milestone payment following first-to-market achievement with CBD produced by fermentation
hyasynth
Oct 23, 2020
About hyasynth
Latest Stories
Archive
About Medium
Terms
Privacy
Teams